首页    期刊浏览 2025年06月16日 星期一
登录注册

文章基本信息

  • 标题:Current therapies for lowering lipoprotein (a)
  • 本地全文:下载
  • 作者:Julian C. van Capelleveen ; Fleur M. van der Valk ; Erik S. G. Stroes
  • 期刊名称:JLR Papers In Press
  • 印刷版ISSN:0022-2275
  • 电子版ISSN:1539-7262
  • 出版年度:2016
  • 卷号:57
  • 期号:9
  • 页码:1612-1618
  • DOI:10.1194/jlr.R053066
  • 语种:English
  • 出版社:American Society for Biochemistry and Molecular Biology
  • 摘要:Lipoprotein (a) [Lp(a)] is a human plasma lipoprotein with unique structural and functional characteristics. Lp(a) is an assembly of two components: a central core with apoB and an additional glycoprotein, called apo(a). Ever since the strong association between elevated levels of Lp(a) and an increased risk for CVD was recognized, interest in the therapeutic modulation of Lp(a) levels has increased. Here, the past and present therapies aiming to lower Lp(a) levels will be reviewed, demonstrating that these agents have had varying degrees of success. The next challenge will be to prove that Lp(a) lowering also leads to cardiovascular benefit in patients with elevated Lp(a) levels. Therefore, highly specific and potent Lp(a)-lowering strategies are awaited urgently.
  • 关键词:apolipoproteins ; drug therapy ; drug therapy/hypolipidemic drugs ; dyslipidemias ; lipoproteins ; lipoprotein(a)
国家哲学社会科学文献中心版权所有